Skip to content

Company information lookup

ONCOSIL MEDICAL LTD (OSL)

Oncology Research and Development

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
OSL 0.096 -4% 0.096 0.098 0.100 0.100 0.096 352,636

ONCOSIL MEDICAL LTD details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code OSL
Securities
Official Listing Date 15 August, 2005
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.oncosil.com.au
Registered Office Address Suite 7, Level 8, Goldfields House, 1 Alfred Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone (02) 9223 3344
Head Office Fax (02) 9221 8535
Share Registry SECURITY TRANSFER REGISTRARS PTY. LIMITED
770 CANNING HIGHWAY, APPLECROSS, WA, AUSTRALIA, 6153
Share Registry Telephone (08) 9315 2333
Directors / Senior Management
Mr Martin Rogers (Chairman)
Dr Neil Frazer (CEO)
Dr Roger Aston (Non Exec. Director)
Mr Lawrence Gozlan (Non Exec. Director)
Mr Nicholas Falzon (CFO)
Company Secretary Mr Peter Casey (Joint Co. Secretary)
Mr Nicholas Falzon (Joint Co. Secretary)
Principal Activities Oncology Research and Development

ONCOSIL MEDICAL LTD announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
17/04/2014   Release of Shares from Voluntary Escrow 1 PDF
11/04/2014   OncoSil Medical Ltd - Investor Update 8 PDF
20/03/2014   Change of Director's Interest Notice 3 PDF
20/03/2014   Notice of Extraordinary General Meeting/Proxy Form 19 PDF
19/03/2014   Amended - Response to ASX Appendix 3X Query 3 PDF
18/03/2014   Undertakings to the ASX 2 PDF
17/03/2014   Response to ASX Appendix 3X Query 4 PDF
17/03/2014 asterix OncoSil Medical commences Pivotal Trial 5 PDF
11/03/2014   Initial Director's Interest Notice 2 PDF
27/02/2014 asterix Appendix 4D and Half Year Report 15 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 Apr 2014 0.096 -4% 0.100 0.096 352,636
16 Apr 2014 0.100 -4.76% 0.105 0.100 1,347,902
15 Apr 2014 0.105 0% 0.110 0.105 324,285
14 Apr 2014 0.105 -4.55% 0.112 0.105 2,210,882
11 Apr 2014 0.110 -8.33% 0.120 0.110 988,660

* Volume of shares shown represents only those shares traded on ASX.

ONCOSIL MEDICAL LTD price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security OSL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security OSL

Warrants & Structured Products

No warrants & Structured Products are available over the security OSL

ASX CFDs

No Contracts For Differences are available over the security OSL